CM
ELV icon

Capula Management’s Elevance Health ELV Stock Holding History

Capula Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-400
Closed -$117K – 839
2026
Q1 		$117K Sell
400
-200
-33% -$65.7K ﹤0.01% 867
2025
Q4 		$210K Buy
600
+200
+50% +$67.6K ﹤0.01% 583
2025
Q3 		$129K Buy
400
+100
+33% +$31.1K ﹤0.01% 689
2025
Q2 		$117K Buy
+300
New +$121K ﹤0.01% 479
2021
Q1 		– Sell
-5,000
Closed -$1.6M – 510
2020
Q4 		$1.6M Buy
+5,000
New +$1.53M 0.08% 185

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capula Management's ELV Position: Q2 2026 in Review

Capula Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 250 shares — an estimated $73.2K sold.

Capula Management first reported a position in ELV in Q4 2020 and held it in 14 quarters. The position peaked at $2.43M in Q4 2022. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Capula Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Capula Management sold 250 Elevance Health shares in Q2 2026, an estimated $73.2K.
  • Capula Management first reported a position in Elevance Health in Q4 2020 and held it in 14 quarters.
  • Capula Management's Elevance Health position peaked at $2.43M in Q4 2022.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.